Westdeutsches Protonentherapiezentrum Essen

What Westdeutsches Protonentherapiezentrum Essen does

Westdeutsches Protonentherapiezentrum Essen (WPE) is a specialized proton therapy center and gGmbH (non-profit limited company) operating within Universitätsmedizin Essen, the University Medical Center of Essen, and the West German Cancer Center (WTZ). Founded in 2005 with clinical operations beginning in 2013, WPE delivers precision proton beam radiotherapy for cancer patients across all ages, with a particular clinical focus on pediatric oncology (approximately 300 children and adolescents treated annually out of ~700 total patients) and rare or complex tumors including brain and CNS malignancies (~45% of cases), sarcomas (~25%), head and neck tumors, eye tumors, and prostate cancer. Its core technology is an IBA (Ion Beam Applications) proton therapy system with pencil beam scanning, deployed across gantry treatment rooms and a specialized fixed beam line, plus a dedicated Eyeline for ocular tumors.

The center combines clinical care with research and training, offering pediatric anesthesia services (over 1,400 children treated under sedation), psychosocial support, case management for international patients (~20% of volume), interdisciplinary tumor boards, and fellowship programs. It is the only proton therapy facility in North Rhine-Westphalia and the largest pediatric proton therapy center in Europe, treating approximately 700 patients per year and reaching the 5,000th patient milestone in February 2025. Revenue is generated through professional services reimbursed via Germany's statutory (GKV) and private (PKV) health insurance systems, with international patients coordinated through case management for cost coverage and logistics. WPE is publicly funded through research grants (notably DFG's €6M AMTEC-PRO graduate college starting October 2025 and ~€1.3M from the EU HARMONIC Horizon 2020 project) and operates as part of a state university medical center rather than a venture-backed or PE-owned entity.

Name

Westdeutsches Protonentherapiezentrum Essen

Legal name

Westdeutsches Protonentherapiezentrum Essen (WPE) gGmbH

Website

https://wpe-uk.de

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

51–100 employees

Short description

WPE is a German proton therapy center within Universitätsmedizin Essen, delivering precision proton beam radiotherapy for cancer patients with a focus on pediatric oncology and complex tumors, serving ~700 patients annually as the largest pediatric proton therapy facility in Europe.

Ownership category

akta.pro rank

Product category

Proton Therapy / Radiation Oncology Services

NAICS

Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Pediatric Hematology & Oncology (HLAKAFAE), Head & Neck Surgery (ENT Oncology) (HLAKAMAF)

Keywords

• Proton therapy services
• Particle beam therapy
• Pediatric radiation oncology
• Precision cancer treatment
• Ocular tumor treatment

Headquarters

HQ city

Essen

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Proton Therapy Treatment Services: WPE provides proton therapy treatment services reimbursed through the German healthcare system (gesetzliche und private Krankenversicherung). Patients require cost coverage approval from their health insurance before treatment begins. International patients coordinate through case management for treatment arrangements.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

WPE provides proton therapy treatment services for cancer patients using precision proton beams delivered via IBA proton therapy systems with pencil beam scanning. The center treats brain/CNS tumors, sarcomas, head and neck tumors, prostate cancer, liver tumors, and eye tumors, with a leading pediatric oncology program treating approximately 300 children per year under sedation. Supporting offerings include pediatric anesthesia, psychosocial services, case management for patient intake, interdisciplinary tumor boards, clinical research, and professional training/fellowships.

Product overview

Westdeutsches Protonentherapiezentrum Essen (WPE) operates as a specialized proton therapy center within the Universitätsmedizin Essen, offering a unified clinical service portfolio centered on proton beam radiotherapy. The core offering is proton therapy treatment for various tumor types (brain/CNS tumors, sarcomas, head/neck tumors, eye tumors, prostate cancer, lymphomas, liver tumors), delivered through IBA-equipped facilities including gantry rooms and a fixed beam line. The center distinguishes itself through its leading pediatric proton therapy program, treating approximately 300 children annually with specialized anesthesia services. Supporting services include psychosocial care, case management, interdisciplinary tumor boards, clinical studies, and the PBTF fellowship training program. Research initiatives like the DFG-funded AMTEC-PRO graduate school and international collaborations (HARMONIC project) complement the clinical offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• Proton Therapy Treatment Services
• Pediatric Proton Therapy
• Eyeline (Eye Tumor Treatment)
• Fixed Beam Line Treatment
• Pediatric Anesthesia Services
• Psychosocial Services
• Case Management
• Tumor Board Consultations
• Clinical Studies and Research
• Fellowship PBTF (Particle Therapy)
• AMTEC-PRO Graduate School

Quantifiable outcome

• Nearly 5,000 patients treated since 2013, with approximately 700 patients treated annually
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• TU DortmundcoreStrategic or Co-development Partner · 1 October 2025Partner in the DFG-funded Graduiertenkolleg AMTEC-PRO (GRK 3043). TU Dortmund's Faculty of Physics hosts the program, with Prof. Kevin Kröninger as spokesperson. 24 doctoral researchers from multiple disciplines conduct research on proton therapy.
• University of Duisburg-EssencoreStrategic or Co-development Partner · 1 October 2025Partner in the DFG-funded Graduiertenkolleg AMTEC-PRO (GRK 3043). Prof. Beate Timmermann serves as medical director of the program. Research focuses on advanced methods and technologies for proton therapy.
• SIOP (International Society for Pediatric Oncology)coreStrategic or Co-development Partner · 11 September 2025WPE co-organized the 6th International CNS GCT Conference 2025 with SIOPE (European Society for Paediatric Oncology) and University Hospital Bonn. The conference brought together 120+ experts from 33 countries to discuss developments in CNS germ cell tumors.
• Universitätsallianz Ruhr (UA Ruhr)coreStrategic or Co-development Partner · 18 November 2024AMTEC-PRO benefits from the excellent research infrastructures of the entire University Alliance Ruhr (UA Ruhr), which encompasses the three Ruhr area universities. The alliance will establish a cross-location guest professorship for particle sciences.
• ESTRO (European Society for Radiotherapy and Oncology)coreStrategic or Co-development Partner · 8 October 2024WPE hosts the 3rd ESTRO/EPTN Workshop on Pediatric Proton Therapy in January 2025. ESTRO provides a platform for radiotherapy expertise and collaborates with WPE on training and education programs.
• EPTN (European Pediatric Tumor Network)coreStrategic or Co-development Partner · 8 October 2024EPTN focuses on interdisciplinary research and exchange of best practices in pediatric oncology. Joint workshops with ESTRO on pediatric proton therapy promote development of more effective therapies.
• Heike Kracht FoundationminorOthers · 1 October 2024Donor foundation that funded the redesign of anesthesia rooms at WPE with child-friendly themes (jungle, underwater world, dinosaur park, outer space). Donation facilitated improved atmosphere for young patients undergoing sedation during treatment.
• PROS LMIC (Pediatric Radiation Oncology Society - Low and Middle Income Countries Working Group)minorStrategic or Co-development Partner · 27 June 2024WPE collaborates with PROS LMIC working group of SIOP Global Health Network to provide training series on radiotherapy in children for colleagues from low and middle income countries where access to such training is limited.
• Apollo Proton Cancer Center, Chennai, IndiaminorStrategic or Co-development Partner · 3 September 2023Delegation visit from Apollo Proton Cancer Center in Chennai, India to exchange ideas and experiences with WPE experts. Both centers use IBA proton therapy systems. Discussion focused on commissioning of the fixed beam line at Apollo Center. The Apollo facility has 2 Gantries and 1 Fixed Beam Line and has treated patients since 2019.
• HARMONIC Project Consortium (24 partners from 13 countries)coreStrategic or Co-development Partner · 1 June 2019European research project investigating long-term health consequences of radiological and radiotherapeutic procedures for children. WPE and University Hospital Essen are the only German partners. Focus areas: radiotherapy dosimetry and pan-European register for pediatric patients. Funded with ~7 million euros from Horizon 2020.
• IBA (Ion Beam Applications)coreTechnology or IntegrationTechnology provider for proton therapy systems. WPE uses IBA proton therapy equipment including gantries and fixed beam lines. Apollo Proton Cancer Center also uses IBA systems, enabling knowledge exchange between facilities.
• University Hospital BonncoreStrategic or Co-development PartnerCollaborator in organizing the 6th International CNS GCT Conference 2025 along with SIOPE and WPE. Prof. Gabriele Calaminus from University Hospital Bonn co-organized the conference.

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• The Christie NHS Proton Therapy Centre: UK NHS proton therapy center treating similar cancer indications including pediatric cases; comparable public-sector specialized radiation oncology practice.
• Rinecker Proton Therapy Center (RPTC): Private proton therapy center in Munich, Germany; directly competes for German and European proton therapy patients with similar IBA-based equipment and indication mix.
• MedAustron: Austrian ion beam therapy center offering proton and carbon ion therapy for cancer; comparable outpatient specialty clinic model with similar technology vendor relationships.
• Paul Scherrer Institute (PSI) Proton Therapy: Swiss research institute operating a long-established proton therapy facility with strong pediatric focus; comparable in treating complex tumors and conducting outcomes research.
• Heidelberg Ion-Beam Therapy Center (HIT): University hospital-based particle therapy center in Germany treating similar oncology indications with comparable proton/carbon ion technology; directly comparable specialty practice and patient profile.

Emerging players

• Apollo Proton Cancer Centre: Indian proton therapy center (2 gantries, 1 fixed beam line) using IBA equipment; comparable technology stack with active knowledge-exchange relationship with WPE.

Broad incumbents

• University of Florida Health Proton Therapy Institute: Major US university-affiliated proton therapy center with high annual patient volume; comparable in academic-center operating model and pediatric focus.
• Massachusetts General Hospital Burr Proton Therapy Center: Harvard-affiliated hospital-based proton therapy program; comparable in academic integration and complex case referral patterns, but part of a much larger oncology franchise.
• MD Anderson Proton Therapy Center: Large US academic cancer center operating one of the most established proton therapy programs; broader oncology portfolio but overlapping in radiation oncology/pediatric indications.

Others

• IBA (Ion Beam Applications): WPE's core technology vendor and the dominant proton therapy system manufacturer; an ecosystem participant whose product roadmap directly shapes WPE's treatment capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCu_xoTu62BUQwYyW5Q6OdAQ
• Facebookfacebook.com/WPEssen
• Instagraminstagram.com/proton_essen
• Xx.com/wpe_essen
• LinkedInlinkedin.com/company/wpessen

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Westdeutsches Protonentherapiezentrum Essen